GlassScriptPhysician profile
Jason A Ahee
NPI 1457357881
$1,420.69
in general payments reported to CMS, 2019-2025
13 companies · $56.71 in 2025
The $56.71 reported for 2025 was less than what a typical Ophthalmology provider received nationally (typical 2025 total: $384).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $337 · 2020: $155 · 2021: $175 · 2022: $125 · 2023: $449 · 2024: $122 · 2025: $56.71.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $628.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $628.43 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Alcon Vision LLC | $789.09 | 2019-2025 | Clareon, Clareon Panoptix Pro |
| Biotissue Holdings INC. | $237.27 | 2019 | |
| New World Medical,INC. | $85.86 | 2023 | |
| Abbott Laboratories | $67.46 | 2019-2020 | |
| Glaukos Corporation | $50.98 | 2020 | |
| Boston Scientific Corporation | $32.68 | 2020-2025 | General - Pain Management |
| Nevro Corp. | $32.30 | 2019-2020 | |
| Tarsus Pharmaceuticals, INC. | $26.03 | 2024 | Xdemvy |
| Kala Pharmaceuticals, INC. | $24.91 | 2020 | |
| Allergan, INC. | $22.46 | 2021 | |
| Oyster Point Pharma, INC. | $21.47 | 2024 | Tyrvaya |
| Tearlab Corp | $15.42 | 2024 | Scoutpro Osmolarity System |
| Novartis Pharmaceuticals Corporation | $14.76 | 2021 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Jason Ahee listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.